World class conference that brings together industry leaders and decision makers to discuss and present advances in biologics production. Tackling current manufacturing challenges in the field of Gene and Cell Therapy. This forum provides a venue for start ups as well as established biotech organization to collaborate, network and exhibit latest innovations in the field.
Senior Manager, Cell Culture GE Healthcare
William G Whitford is Sr. Manager, Cell Culture, GE Healthcare in Logan, UT with over 20 years experience in biotechnology product and process development. He joined the company 12 years ago as a team leader in R&D developing products supporting biomass expansion, protein expression and virus secretion in mammalian and invertebrate cell lines. Products he has commercialized include, defined and animal product-free hybridoma media, fed-batch supplements, and aqueous lipid dispersions. An invited lecturer at international conferences, he has published over 250 articles, book chapters and patents in a number of fields in the bioproduction arena. He now enjoys such industry activities as serving on the editorial advisory board for BioProcess International.
Vice President, Technical applications, Maxcyte Inc.
James Brady, Ph.D., is Vice President of Tehcnical Applications and Customer Support at Maxcyte Inc., where he has worked since 2004. Prior to joining Maxcyte, Dr. Brady was a senior scientist at Genetic Therapy Inc. ( a Novartis subsidiary) and a group leader at MetaMorphix, Inc.
Associate Professor, UCSD
Tuning the CHO secretory pathway through a genome-scale systems biology approach
Process Science Manager, Thermo Fisher Scientific
Doan Tran is a Process Science Manager, Thermo Fisher Scientific, responsible for technical engagement with customers to insure they gain maximum benefit from Gibco catalog or custom Bioproduction cell culture products. Her current role involves support of cell line development, process development, media development and technical operations consultation in cell culture.